Megan Hall brings interdisciplinary expertise at the intersection of market access, health policy, and biomedical research. She specializes in monitoring emerging FDA policies and translating regulatory science into actionable insights for pipeline management and asset strategy for pharmaceutical manufacturers. Prior to joining Avalere, Megan completed an M.S. in Global Public Health from Georgetown University, with a concentration in health systems strengthening and program monitoring and evaluation, including a research practicum on vector-borne diseases in South India. She holds a B.S. in Biology from Stanford University and applies strong quantitative and qualitative research skills across her work.
